Identification | Back Directory | [Name]
4-Bromo-2-(methylsulfonyl)pyrimidine | [CAS]
1208538-52-6 | [Synonyms]
4-Bromo-2-(methylsulfonyl) 4-Bromo-2-(methylsulfonyl)pyrimidine Pyrimidine, 4-bromo-2-(methylsulfonyl)- 4-Bromo-2-(methylsulfonyl)pyrimidine ISO 9001:2015 REACH | [Molecular Formula]
C5H5BrN2O2S | [MDL Number]
MFCD12406118 | [MOL File]
1208538-52-6.mol | [Molecular Weight]
237.07 |
Chemical Properties | Back Directory | [Melting point ]
111-112 °C | [Boiling point ]
393.7±34.0 °C(Predicted) | [density ]
1.771±0.06 g/cm3(Predicted) | [storage temp. ]
under inert gas (nitrogen or Argon) at 2-8°C | [pka]
-4.97±0.20(Predicted) | [Appearance]
Off-white to light yellow Solid |
Hazard Information | Back Directory | [Synthesis]
General procedure for the synthesis of 4-bromo-2-(methylthio)pyrimidine from 2-methylthio-4-bromopyrimidine: ammonium molybdate tetrahydrate (1.09 g, 0.88 mmol, 0.03 eq.) was added in batches to a stirred solution of 30% H2O2 (6 g, 29.4 mmol, 1 eq.) at 0 °C for 20 min. Subsequently, a solution of 4-bromo-2-(methylthio)pyrimidine (6 g, 29.41 mmol, 1 eq.) was slowly added, keeping the reaction temperature at 0 °C. After addition, the reaction mixture was brought to room temperature and stirred for 3 hours. The reaction progress was monitored by TLC. Upon completion of the reaction, the reaction mixture was concentrated to a crude residue, diluted with cold water and then extracted with dichloromethane (DCM, 3 x 100 mL). The organic layers were combined, washed sequentially with 5% H2SO4 solution and water, dried over anhydrous Na2SO4 and concentrated to give the crude product. The crude product was purified by silica gel column chromatography (100-200 mesh) with the eluent being a petroleum ether solution of 0-40% ethyl acetate, resulting in 4-bromo-2-(methylsulfonyl)pyrimidine (6 g, 86% yield) as an off-white solid.LCMS: [M + H]+ 238.84. | [References]
[1] ChemMedChem, 2016, vol. 11, # 22, p. 2522 - 2533 [2] Organic Letters, 2011, vol. 13, # 19, p. 5000 - 5003 [3] Patent: WO2017/147700, 2017, A1. Location in patent: Paragraph 001095 |
|
Company Name: |
Tetranov Biopharm
|
Tel: |
13526569071 |
Website: |
http://www.leadmedpharm.com/index.html |
Company Name: |
NovoChemy Ltd.
|
Tel: |
021-31261262/ 49 (0)17662837245 |
Website: |
www.novochemy.com |
|